PSYCHIATRY HOME

2003/2004 GRAND ROUNDS
"The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this educational activity for a maximum of one category 1 credit(s) toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity."

September 2003

9/2/03
11:00am

Auditorium
2nd Floor
CPM

No Grand Rounds Scheduled

9/9/03
11:00am

Auditorium
2nd Floor
CPM

No Grand Rounds Scheduled

9/16/03
11:00am

Auditorium
2nd Floor
CPM

No Grand Rounds Scheduled

9/23/03

Auditorium
2nd Floor
CPM

No Grand Rounds Scheduled

9/30/03

Auditorium
2nd Floor
CPM

No Grand Rounds Scheduled

Questions or comments concerning these activities? Write, Call, FAX, or E-mail:
Carol Schaffhausen, Education & Training Program Manager
The University of Alabama at Birmingham
115 Smolian Psychiatric Clinic
1700 Seventh Avenue South
Birmingham, AL 35294-0018
PHONE 934-1306 FAX 934-4659 cschaff@uabmc.edu

PSYCHIATRY HOME CLINICAL SERVICES Center for Psychiatric Medicine Adult Psychiatry Child/Adolescent Psychiatry Geriatric Psychiatry Addiction Recovery Program Community Psychiatry EDUCATION Psychiatry Residency Training Psychiatry Fellowship Programs Medical Education Psychology Training Grand Rounds RESEARCH Clinical Research Behavioral Neurobiology LINKS Other Psychiatry Sites	*The Department of Psychiatry* *and* *Behavioral Neurobiology*
	2003/2004 GRAND ROUNDS "The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity." October 2003
	10/7/03 11:00am	Auditorium 2nd Floor CPM	From Benchtop to Bedside: Applying Clinical Outcomes to the Treatment of Psychosis Rajiv Tandon, M.D., Professor of Psychiatry University of Michigan Hospitals Director, Hospital Services and Community Psychiatry Division Objectives: 1) To discuss how PANSS and CGI improvements relate to clinical practice 2) Identify factors that contribute to patient non-compliance and review strategies to increase compliance 3) Improving functional outcomes 4) Appropriate dosing strategies *We gratefully acknowledge an educational grant from Bristol-Myers Squibb to support Dr. Tandon's visit.*
	10/14/03 11:00am	Auditorium 2nd Floor CPM	NO GRAND ROUNDS SCHEDULED
	10/21/03 11:00am	Auditorium 2nd Floor CPM	CANCELLED - Dr. Schwartz unable to travel for health reasons. Rescheduled for March 9, 2004 Systems Neuroscience and Newer-Generation Antipsychotics Michael Alan Schwartz, M.D., Clinical Professor of Psychiatry Case Western Reserve University School of Medicine Lecturer in Psychiatry, Johns Hopkins University School of Medicine Psychoactive medications do not target lesions, they modulate networks and circuits in the brain. Therefore, they function more as "fine tuners" rather than as "magic bullets." The practical consequences of this for the clinician will be clarified in this lecture. Goals and Objectives: 1. Participants will learn about recent developments in system neuroscience and their practical application to schizophrenia and related disorders. 2. Participants will learn about the key concepts of networks, neuromodulation and neuroplasticity and their relationship to beneficial effects as well as side effects of newer generation antipsychotics. 3. Participants will learn how to apply this knowledge to the treatment of patients with schizophrenia and related psychiatric disorders. References: Spitzer M, The Mind Within the Net. MIT Press 1999. Quartz SR and Sejnowski TJ. Liars, Lovers and Heros. HarperCollins NY 2002. Gazzaniga MS (Ed) The New Cognitive Neuroscience. MIT Press, 2000. *We gratefully acknowledge an educational grant from AstraZeneca to support Dr. Schwartz's visit.*
	10/28/03	Auditorium 2nd Floor CPM	The Art of Mood Stabilization in Bipolar Disorder: An Evidence-Based Approach James G. Barbee, M.D., George C. Dunn MD Professor and Vice Chair Medical Director, LSUHSC Behavioral Sciences Center Department of Psychiatry, Louisiana State University A number of new, innovative pharmacological agents have recently emerged for use in the bipolar patient. Objectives: After this presentation the participants shall be able to: 1) Identify all the agents that have currently been reported to be effective in bipolar disorder. 2) Use an eveidence-based approach to review the currently existing literature regarding the efficacy and safety of these agents in acute mania, acute bipolar depression and the maintenance phase of bipolar disorder. 3) Apply this information to an understanding of the state-of-the-art use of all of these agents in the long-term management of bipolar disorder. *We gratefully acknowledge an educational grant from GlaxoSmithKline NeuroHealth to support Dr. Barbee's visit.*

	Questions or comments concerning these activities? Write, Call, FAX, or E-mail: Carol Schaffhausen, Education & Training Program Manager The University of Alabama at Birmingham 115 Smolian Psychiatric Clinic 1700 Seventh Avenue South Birmingham, AL 35294-0018 PHONE 934-1306 FAX 934-4659 cschaff@uabmc.edu

PSYCHIATRY HOME CLINICAL SERVICES Center for Psychiatric Medicine Adult Psychiatry Child/Adolescent Psychiatry Geriatric Psychiatry Addiction Recovery Program Community Psychiatry EDUCATION Psychiatry Residency Training Psychiatry Fellowship Programs Medical Education Psychology Training Grand Rounds RESEARCH Clinical Research Behavioral Neurobiology LINKS Other Psychiatry Sites	*The Department of Psychiatry* *and* *Behavioral Neurobiology*
	2003/2004 GRAND ROUNDS "The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity." November 2003
	11/4/03 11:00am	Auditorium 2nd Floor CPM	NO GRAND ROUNDS SCHEDULED
	11/11/03 11:00am	Auditorium 2nd Floor CPM	Diagnosis of Delirium in Pediatric Postoperative Patients D. Richard Martini, M.D., Associate Professor Department of Psychiatry and Behavioral Sciences Northwestern University, Feinberg School of Medicine Clinical Director, Intake, Consultation, and Emergency Services Department of Child and Adolescent Psychiatry, Children's Memorial Hospital Delirium is a frequent psychiatric consequence of medical illness and treatment, substance use or withdrawal, and toxin exposure. The disorder is rarely diagnosed in the pediatric population due to an absence of standardized assessment instruments and the presence of developmental limitations in communication and cognition. The presentation reviews the development of the Children’s Delirium Scale for pediatric postoperative patients and the progressive identification of the disorder in that population. Goals and Objectives: Standardized assessment of delirium in pediatric patients Characteristics of delirium in pediatric patients postoperatively Need for additional study in specific pediatric populations
	11/18/03 11:00am	Auditorium 2nd Floor CPM	CANCELLED DUE TO AIR TRAVEL DIFFICULTIES Rescheduled for April 13, 2004 Dialectical Behavior Therapy for Borderline Personality Disorder and other Multi-Problem Patients Clive J. Robins, Ph.D., ABPP Associate Clinical Professor, Departments of Psychology and Psychiatry Director of the Behavior Research and Therapy Program Duke University Medical Center Behavior Therapy (DBT, Linehan, 1993) is a systematic cognitive-behavioral treatment approach to working with individuals who meet criteria for borderline personality disorder (BPD), especially those with chronic patterns of suicidal and other severe dysfunctional behaviors. This presentation will provide an overview of the treatment approach and summarize results of several studies that have supported its efficacy for borderline personality disorder, substance abuse, eating disorders and other problems. *Goals and Objectives:* At the end of the presentation, participants should be able to: 1) Describe the components of a comprehensive DBT program and their functions 2) Prioritize behaviors to target in a patient with BPD or other patients with multiple problems 3) Explain the range of strategies available in DBT to help patients change targeted behaviors 4) Summarize evidence supporting the efficacy of DBT
	11/25/03 11:00am	Auditorium 2nd Floor CPM	NO GRAND ROUNDS SCHEDULED THANKSGIVING

	Questions or comments concerning these activities? Write, Call, FAX, or E-mail: Carol Schaffhausen, Education & Training Program Manager The University of Alabama at Birmingham 115 Smolian Psychiatric Clinic 1700 Seventh Avenue South Birmingham, AL 35294-0018 PHONE 934-1306 FAX 934-4659 cschaff@uabmc.edu

PSYCHIATRY HOME CLINICAL SERVICES Center for Psychiatric Medicine Adult Psychiatry Child/Adolescent Psychiatry Geriatric Psychiatry Addiction Recovery Program Community Psychiatry EDUCATION Psychiatry Residency Training Psychiatry Fellowship Programs Medical Education Psychology Training Grand Rounds RESEARCH Clinical Research Behavioral Neurobiology LINKS Other Psychiatry Sites	*The Department of Psychiatry* *and* *Behavioral Neurobiology*
	2003/2004 GRAND ROUNDS "The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity." December 2003
	12/2/03 11:00am	Auditorium 2nd Floor CPM	Disaster Mental Health - A Public Health Approach Anthony Taiwai Ng, M.D. Chairperson of Committee on Psychiatric Dimensions of Disaster American Psychiatric Association Director, Reich, Ng & Associates, LLC Emergency Medical Management Consultants Dr. Ng was the director of the Disaster Psychiatry Outreach, the psychiatric group which lead the mental health response in NYC after 9/11 Two years after the events of September 11^th, the mental health risks of terrorism and disasters continue to be of significant concerns in the United States. Several public health emergency events, including the SARS outbreak have further generated concerns on how the psychiatric community can anticipate and prepare for the psychological and behavioral consequences of these events. This presentation will highlight the role of mental health in public health emergencies such as large disease outbreaks, disasters, or terrorism. The presentation will also present strategies on how secure a bridge between mental health and public health to ensure adequate disaster preparedness. *Objectives:* At the conclusion of the workshop, the audience will have: 1) A greater understanding of the close link between mental health and public health in disaster preparedness and response to terrorism, disasters, and other public health emergencies. 2) A better understanding of some of the clinical issues and system issues in the acute aftermath of a disaster. 3) The audience will also learn the application of that knowledge into their clinical work. References: Ursano, Robert J, Fullerton , Carol S., Norwood Ann E. (eds) Terrorism and disaster: individual and community mental health interventions. Cambridge Press, New York, 2003. Institute of Medicine . Preparing for the psychological consequences of terrorism: A public health strategy. National Academies of Sciences, National Academic Press, Washington, DC. (2003). *We gratefully acknowledge an educational grant from Pfizer Pharmaceuticals to support Dr. Ng's visit.*
	12/9/03 11:00am	Auditorium 2nd Floor CPM	Re-scheduled for January 6, 2004 Asperger's and Autism: Through the Looking Glass Margaret Renee Acker, M.D. PGY-IV Resident in Psychiatry UAB Department of Psychiatry & Behavioral Neurobiology Goals and Objectives: To learn more about 1) higher functioning Autism. 2) Asperger's Syndrome 3) how persons affected with these illnesses function in society 4) To explore possible improvements in social support for people affected with these illnesses
	12/16/03 11:00am	Auditorium 2nd Floor CPM	Determing Differences in Antidpressant Efficacy Norman Sussman, M.D., Professor of Psychiatry New York University School of Medicine *Goals and Objectives:* 1. Review concepts of remission in depression 2. Review how studies are designed to determine differences in remission 3. Statistical techniques for analyzing results of studies *We gratefully acknowledge an educational grant from Wyeth Pharmaceuticals to support Dr. Sussman's visit.*
	2/23/03 11:00am	Auditorium 2nd Floor CPM	NO GRAND ROUNDS SCHEDULED. HAPPY HOLIDAYS!
	12/30/03	Auditorium 2nd Floor CPM	NO GRAND ROUNDS SCHEDULED. HAPPY HOLIDAYS!
	Questions or comments concerning these activities? Write, Call, FAX, or E-mail: Carol Schaffhausen, Education & Training Program Manager The University of Alabama at Birmingham 115 Smolian Psychiatric Clinic 1700 Seventh Avenue South Birmingham, AL 35294-0018 PHONE 934-1306 FAX 934-4659 cschaff@uabmc.edu

PSYCHIATRY HOME CLINICAL SERVICES Center for Psychiatric Medicine Adult Psychiatry Child/Adolescent Psychiatry Geriatric Psychiatry Addiction Recovery Program Community Psychiatry EDUCATION Psychiatry Residency Training Psychiatry Fellowship Programs Medical Education Psychology Training Grand Rounds RESEARCH Clinical Research Behavioral Neurobiology LINKS Other Psychiatry Sites	*The Department of Psychiatry* *and* *Behavioral Neurobiology*
	2003/2004 GRAND ROUNDS "The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity." January 2004
	1/6/04 11:00am	Auditorium 2nd Floor CPM	Asperger's and Autism: Through the Looking Glass Margaret Renee Acker, M.D. PGY-IV Resident in Psychiatry UAB Department of Psychiatry & Behavioral Neurobiology Goals and Objectives: To learn more about 1) higher functioning Autism. 2) Asperger's Syndrome 3) how persons affected with these illnesses function in society 4) To explore possible improvements in social support for people affected with these illnesses
	1/13/04 11:00am	Auditorium 2nd Floor CPM	ADHD and Mood Disorders Jefferson Bruce Prince, M.D. Instructor in Psychiatry, Harvard Medical School, Boston, MA Director, Child and Adolescent Psychiatry, North Shore Medical Center, Salem, MA Assistant Psychiatrist, Massachusetts General Hospital Associate Chief of Psychiatry, Salem Hospital, Salem, MA *Goals and Objectives:* 1) To be familiar with the presentation of ADHA and Depression in the child, adolescent, and adult. 2) Be familiar with the presentation of ADHD and mania in children, adolescents, and adults. 3) Be familiar with the pharmacotherapy of ADHD and mood disorders. *We gratefully acknowledge an educational grant from McNeil Pharmaceuticals to support Dr. Prince's visit.*
	1/20/04 11:00am	Auditorium 2nd Floor CPM	Innovations in Antipsychotic Therapy Jeffrey Lieberman, M.D., Vice Chair and Professor of Psychiatry Thad and Alice Eure Distinguished Professor of Psychiatry, Pharmacology, and Radiology Director, Mental Health and Neuroscience Clinical Research Center University of North Carolina at Chapel Hill School of Medicine Dr. Lieberman’s research has focused on the neurobiology, pharmacology and treatment of schizophrenia and related psychotic disorders. In this context, his work has advanced our understanding of the natural history and phenomenology of schizophrenia and its pathophysiological basis, and the mechanism of action and clinical effectiveness of antipsychotic drugs. He currently serves as the Principal Investigator of the Clinical Antipsychotic Trials of Intervention Effectiveness Research Program (CATIE) and the Silvio O. Conte Center for the Neuroscience of Mental Disorders sponsored by the NIMH. His research has been supported by grants from the National Institutes of Health (including Research Career Development and MERIT awards) and the NARSAD, Stanley, and Mental Illness Foundations, and has been reported in more than 200 articles in the scientific literature. *Goals and Objectives:* 1) To inform audience about current evidence for pharmcologic RX for schizophrenia 2) To inform audience of new strategies for early intervention 3) To inform audience about new strategies for novel drug development *We gratefully acknowledge an educational grant from The Chatham Institute to support Dr. Lieberman's visit.*
	1/27/04 11:00am	Auditorium 2nd Floor CPM	Differentiating Among the SSRI's: What About Dopamine? John Joseph Miller, M.D. Medical Director, Center for Health and Well-Being Exeter, NH *Goals and Objectives:* 1) Appreciate the diverse secondary binding property differences among the SSRI's 2) Understand the clinical consequences of the varying SSRI secondary binding properties 3) Describe the benefits of synaptic dopamine preservation in the context of synaptic serotonin elevation. *We gratefully acknowledge an educational grant from Pfizer to support this visit.*

	Questions or comments concerning these activities? Write, Call, FAX, or E-mail: Carol Schaffhausen, Education & Training Program Manager The University of Alabama at Birmingham 115 Smolian Psychiatric Clinic 1700 Seventh Avenue South Birmingham, AL 35294-0018 PHONE 934-1306 FAX 934-4659 cschaff@uabmc.edu

PSYCHIATRY HOME CLINICAL SERVICES Center for Psychiatric Medicine Adult Psychiatry Child/Adolescent Psychiatry Geriatric Psychiatry Addiction Recovery Program Community Psychiatry EDUCATION Psychiatry Residency Training Psychiatry Fellowship Programs Medical Education Psychology Training Grand Rounds RESEARCH Clinical Research Behavioral Neurobiology LINKS Other Psychiatry Sites	*The Department of Psychiatry* *and* *Behavioral Neurobiology*
	2003/2004 GRAND ROUNDS "The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity." February 2004
	2/3/04 11:00am	Auditorium 2nd Floor CPM	The Neuropathology of Schizophrenia Richard E. Powers, M.D. Associate Professor, Pathology University of Alabama at Birmingham This presentation discusses the current thinking on the neuropathology of schizophrenia. Positive and negative symptoms are related to structural brain abnormalities of the frontal and temporal cortices. The known gross and microscopic abnormalities will be contrasted with the potential etiologies including genetic predisposition and developmental brain abnormalities. Objectives: 1) To define the neuro-anatomy of positive and negative symptoms. 2) To describe the neuropathology of auditory hallucinations, thought disorder and negative symptoms. 3) To define structural and microscopic changes that occur in the brains of patients with schizophrenia. 4) To contrast the neuropathology of schizophrenia with the double hit theory of causation.
	2/10/04 11:00am	Auditorium 2nd Floor CPM	Pediatric Bipolar Disorder James T. Cullinan, DO, Assistant Professor Latamia White, M.D., 2nd Year Subspecialist in Child/Adolescent Psychiatry Child/Adolescent Division Department of Psychiatry and Behavioral Neurobiology University of Alabama at Birmingham Case presentation with video of an adolescent with bipolar disorder and the challenges of treating this age group and their families. Review of the diagnosis criteria and treatments for pediatric bipolar disorder will also be presented. Objectives: 1) To enhance the understanding of the diagnostic challenges involved with pediatric bipolar disorder. 2) To enhance the appreciation for the unique challenges in treating children and adolescents with bipolar disorder. 3) To help to improve clinical decision making for the diagnosis and treatment of pediatric bipolar disorder.
	2/17/04 11:00am	Auditorium 2nd Floor CPM	Department of Psychiatry & Behavioral Neurobiology Eighth Residents Versus Faculty Scholar's Bowl Moderated by Daniel C. Dahl, M.D. Assistant Professor and Vice Chair for Education and Training Department of Psychiatry and Behavioral Neurobiology University of Alabama at Birmingham Two teams fo head-to-head in a challenging contest of general and psychiatric knowledge. Dr. Dahl will serve as moderator and will provide a series of challenging psychiatric as well as general knowledge questions. You won't want to miss it! Objectives: 1) To review challenging questions from PRITE. 2) To review information from Kaplan and Sadock. 3) To test general knowledge.
	2/24/04	Auditorium 2nd Floor CPM	The Wounded Healers Syed Aftab, M.D., PGY-IV Resident in Psychiatry UAB Department of Psychiatry & Behavioral Neurobiology A look at physician suicide. Literature review, causes and prevention. Goals and Objectives: The purpose of this presentation is to bring to light this much overlooked topic. References: TBA

	Questions or comments concerning these activities? Write, Call, FAX, or E-mail: Carol Schaffhausen, Education & Training Program Manager The University of Alabama at Birmingham 115 Smolian Psychiatric Clinic 1700 Seventh Avenue South Birmingham, AL 35294-0018 PHONE 934-1306 FAX 934-4659 cschaff@uabmc.edu

PSYCHIATRY HOME CLINICAL SERVICES Center for Psychiatric Medicine Adult Psychiatry Child/Adolescent Psychiatry Geriatric Psychiatry Addiction Recovery Program Community Psychiatry EDUCATION Psychiatry Residency Training Psychiatry Fellowship Programs Medical Education Psychology Training Grand Rounds RESEARCH Clinical Research Behavioral Neurobiology LINKS Other Psychiatry Sites	*The Department of Psychiatry* *and* *Behavioral Neurobiology*
	2003/2004 GRAND ROUNDS "The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity." March 2004
	3/2/04 11:00am	Auditorium 2nd Floor CPM	Dementia: Diagnosis to Death Daniel D. Christensen, M.D. Clinical Professor of Psychiatry, Clinical Professor of Neurology, Adjunct Professor of Pharmacology The University of Utah Neuropsychiatric Institute Salt Lake City, Utah Goals and Objectives: To 1) describe the current increasing prevalence of Alzheimer's Disease in the United States. 2) outline important elements of early diagnosis 3) present a case from early diagnosis to death 4) review autopsy findings and discuss their relevance to the clinical course References: Practical Principles for the Management of Alzheimer's Disease. Christensen DD. Prim Care Companion J Clin Psychiatry. 2002 Apr; 4(2): 63-69. *We gratefully acknowledge an educational grant from Pfizer to support this visit.*
	3/9/04 11:00am	Auditorium 2nd Floor CPM	Systems Neuroscience and Newer-Generation Antipsychotics Michael Alan Schwartz, M.D., Clinical Professor of Psychiatry Case Western Reserve University School of Medicine Lecturer in Psychiatry, Johns Hopkins University School of Medicine Psychoactive medications do not target lesions, they modulate networks and circuits in the brain. Therefore, they function more as "fine tuners" rather than as "magic bullets." The practical consequences of this for the clinician will be clarified in this lecture. Goals and Objectives: 1. Participants will learn about recent developments in system neuroscience and their practical application to schizophrenia and related disorders. 2. Participants will learn about the key concepts of networks, neuromodulation and neuroplasticity and their relationship to beneficial effects as well as side effects of newer generation antipsychotics. 3. Participants will learn how to apply this knowledge to the treatment of patients with schizophrenia and related psychiatric disorders. References: Spitzer M, The Mind Within the Net. MIT Press 1999. Quartz SR and Sejnowski TJ. Liars, Lovers and Heros. HarperCollins NY 2002. Gazzaniga MS (Ed) The New Cognitive Neuroscience. MIT Press, 2000. *We gratefully acknowledge an educational grant from AstraZeneca to support Dr. Schwartz's visit.*
	3/16/04 11:00am	Auditorium 2nd Floor CPM	Bipolar Disorder versus Borderline Personality Disorder Roopashri Kurse, M.D., PG-III Resident UAB Department of Psychiatry & Behavioral Neurobiology The speaker will explore the softer end of the bipolar spectrum disorder. Since the symptoms overlap with personality disorder this is an attempt to sort out and objectively look at hard markers of Bipolar disorders. This presentation will also look at co morbidities of both bipolar spectrum disorder and Borderline Personality disorder from a diagnostic as well as management perspective. The speaker will present clinical vignettes during the presentation. Goals and Objectives: 1. To review the "softer" signs of the bipolar spectrum disorder. 2. To review the co morbidities of the Bipolar disorder and Borderline personality disorder. 3. To establish the differences between the softer end of the bipolar spectrum disorders and Borderline personality disorder.
	3/23/04	Auditorium 2nd Floor CPM	Spring Break
	3/30/04	Auditorium 2nd Floor CPM	Barriers to Good Doctor-Patient Communication Thad Ryals, M.D., PGY-IV Resident in Psychiatry UAB Department of Psychiatry & Behavioral Neurobiology Research is presented on the importance of doctor-patient communication, different ways doctors communicate and common problems in communication. Methods for improving the effectiveness of communication is also discussed, with clinical examples from the speaker's own experience. Goals and Objectives: 1. To familiarize the audience with research about doctor-patient communication 2. To explore common barriers to effective communication 3. To examine techniques of effective communication
	Questions or comments concerning these activities? Write, Call, FAX, or E-mail: Carol Schaffhausen, Education & Training Program Manager The University of Alabama at Birmingham 115 Smolian Psychiatric Clinic 1700 Seventh Avenue South Birmingham, AL 35294-0018 PHONE 934-1306 FAX 934-4659 cschaff@uabmc.edu

PSYCHIATRY HOME CLINICAL SERVICES Center for Psychiatric Medicine Adult Psychiatry Child/Adolescent Psychiatry Geriatric Psychiatry Addiction Recovery Program Community Psychiatry EDUCATION Psychiatry Residency Training Psychiatry Fellowship Programs Medical Education Psychology Training Grand Rounds RESEARCH Clinical Research Behavioral Neurobiology LINKS Other Psychiatry Sites	*The Department of Psychiatry* *and* *Behavioral Neurobiology*
	2003-2004 GRAND ROUNDS "The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity." April 2004
	4/6/04 11:00am	Auditorium 2nd Floor CPM	Animal-Assisted Therapy (AAT) Jennifer L. Grant, LCSW, Instructor in Psychiatry Lizzie Grant, Certified Animal-Assisted Therapy Dog & Winner of the Honorary Consumer Award from the Alabama Department of Mental Health Office of Consumer Relations UAB Department of Psychiatry and Behavioral Neurobiology To see award information and photos click here. Goals and Objectives: 1) To learn the definition of animal-assisted therapy (AAT), a general overview of its many uses, and its specific uses at CPP. 2) To learn the benefits of AAT, whether through anecdotal or scientific data, by reviewing the literature and hearing reports of AAT interventions at CPP. 3) To Identify the need for further research into the benefits of AAT.
	4/13/04 11:00am	Auditorium 2nd Floor CPM	ANNUAL C.J. ROSECRANS, Ph.D. MEMORIAL LECTURE Dialectical Behavior Therapy for Borderline Personality Disorder and other Multi-Problem Patients Clive J. Robins, Ph.D., ABPP Associate Clinical Professor, Departments of Psychology and Psychiatry Director of the Behavior Research and Therapy Program Duke University Medical Center Behavior Therapy (DBT, Linehan, 1993) is a systematic cognitive-behavioral treatment approach to working with individuals who meet criteria for borderline personality disorder (BPD), especially those with chronic patterns of suicidal and other severe dysfunctional behaviors. This presentation will provide an overview of the treatment approach and summarize results of several studies that have supported its efficacy for borderline personality disorder, substance abuse, eating disorders and other problems. *Goals and Objectives:* At the end of the presentation, participants should be able to: 1) Describe the components of a comprehensive DBT program and their functions 2) Prioritize behaviors to target in a patient with BPD or other patients with multiple problems 3) Explain the range of strategies available in DBT to help patients change targeted behaviors 4) Summarize evidence supporting the efficacy of DBT
	4/20/04 11:00am	Auditorium 2nd Floor CPM	TBA Mahija Mungara, M.D., PGY-IV Resident in Psychiatry UAB Department of Psychiatry and Behavioral Neurobiology Goals and Objectives: TBA References: TBA
	4/27/04	Auditorium 2nd Floor CPM	CANCELLED Due to the unavailability of the auditorium Rescheduled for September 28, 2004 Awareness, Attribution, and Adherence in Schizophrenia Charlie L. Swanson, Jr., M.D., Assistant Professor UAB Department of Psychiatry and Behavioral Neurobiology

	Questions or comments concerning these activities? Write, Call, FAX, or E-mail: Carol Schaffhausen, Education & Training Program Manager The University of Alabama at Birmingham 115 Smolian Psychiatric Clinic 1700 Seventh Avenue South Birmingham, AL 35294-0018 PHONE 934-1306 FAX 934-4659 cschaff@uabmc.edu

PSYCHIATRY HOME CLINICAL SERVICES Center for Psychiatric Medicine Adult Psychiatry Child/Adolescent Psychiatry Geriatric Psychiatry Addiction Recovery Program Community Psychiatry EDUCATION Psychiatry Residency Training Psychiatry Fellowship Programs Medical Education Psychology Training Grand Rounds RESEARCH Clinical Research Behavioral Neurobiology LINKS Other Psychiatry Sites	*The Department of Psychiatry* *and* *Behavioral Neurobiology*
	2003-2004 GRAND ROUNDS "The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity." May 2004
	5/4/04 11:00am	Auditorium 2nd Floor CPM	NO GRAND ROUNDS SCHEDULED APA - MAY 1 - 6 NEW YORK
	5/11/04 11:00am	Auditorium 2nd Floor CPM	Early Childhood Mental Health and the Therapeutic Preschool Susan Isbill, Ph.D., Assistant Professor Tolulope Aduroja, M.D., Child Sub-Specialty Fellow UAB Department of Psychiatry & Behavioral Neurobiology The presentation will include discussion of some significant issues of early childhood mental health and the use of the therapeutic preschool as an intervention *Goals and Objectives:* At the end of the presentation, participants should be able to: 1) Discuss basic mental health concerns of the younger child population 2) Identify appropriate mental health intervention strategies for the preschool population
	5/18/04 11:00am	Auditorium 2nd Floor CPM	Synaptic Pharmacology of Antidepressants: Relation to Clinical Effects Elliott Richelson, M.D. Professor of Psychiatry & Pharmacology, Mayo Clinic College of Medicine, Rochester, MN Consultant in Psychiatry & Pharmacology, Mayo Clinic, Jacksonville, FL This lecture will be an overview of the effects of antidepressants at the level of the synapse. This pharmacology includes blockade of certain transporters and receptors for neurotransmitters. Theories about the mechanism of action will be discussed briefly. Goals and Objectives: The learner will be able to understand the theoretical basis for antidepressant activity. The learner will be able to identify clinical consequences of blocking transporters for norepinephrine, serotonin, and dopamine and of blocking histamine H1, muscarinic, and alphal- adrenergic receptors. The learner will be able to identify the significant drug interactions of antidepressants based upon their pharmacological effects at the synapse. References: E. Richelson: Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance. Journal of Clinical Psychiatry 64 Suppl 13:5-12, 2003. E. Richelson: The clinical relevance of antidepressant interaction with neurotransmitter transporters and receptors. Psychopharmacology Bulletin 36:133-149, 2002 E. Richelson: The pharmacology of antidepressants. Mayo Clinic Proceedings 76: 511-527, 2001. *We gratefully acknowledge an educational grant from Pfizer to support Dr. Richelson's visit.*
	5/25/04	Auditorium 2nd Floor CPM	TBA Roger Stewart McIntyre, MD, FRCPC Head, Mood Disorders Psychopharmacology Unit University Health Network Assistant Professor of Psychiatry, University of Toronto Dr. McIntyre’s clinical and research interests are in the development of novel treatment strategies for both Unipolar and Bipolar Disorder. He has been a Principal Investigator in national and Co-Investigator in international clinical trials. His research has focused on the efficacy and safety of novel antipsychotics, anticonvulsants, unimodal antidepressants and other candidate mood disorder treatments. He has a further interest in delineating biological mechanisms which presage psychotropic medication adverse events. Goals and Objectives: TBA References: TBA *We gratefully acknowledge an educational grant from Janssen to support Dr. McIntyre's visit.*
	Questions or comments concerning these activities? Write, Call, FAX, or E-mail: Carol Schaffhausen, Education & Training Program Manager The University of Alabama at Birmingham 115 Smolian Psychiatric Clinic 1700 Seventh Avenue South Birmingham, AL 35294-0018 PHONE 934-1306 FAX 934-4659 cschaff@uabmc.edu